Immediate Impact
3 by Nobel laureates 10 from Science/Nature 78 standout
Citing Papers
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Works of Eva Carrasco being referenced
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
2016
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2− breast cancer patients: results from the GEICAM 9906 trial
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Eva Carrasco | 1424 | 1093 | 466 | 76 | 1.9k | |
| Edda Simoncini | 1700 | 1039 | 740 | 99 | 2.5k | |
| Silvia Dellapasqua | 1118 | 1033 | 316 | 54 | 1.7k | |
| Véronique Becette | 1019 | 963 | 402 | 53 | 2.2k | |
| Kristi McIntyre | 1532 | 939 | 391 | 37 | 1.8k | |
| Jonathan D. Marotti | 1298 | 1087 | 494 | 83 | 2.4k | |
| Giuseppe Cancello | 1440 | 1097 | 425 | 44 | 2.0k | |
| H. Hausmaninger | 1317 | 893 | 236 | 53 | 2.1k | |
| G. Peruzzotti | 1282 | 1206 | 358 | 44 | 2.0k | |
| Marina Parton | 924 | 720 | 290 | 48 | 1.5k | |
| P. Kelly Marcom | 1125 | 649 | 291 | 48 | 1.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...